13,900,000 Shares1 POINT Biopharma Global Inc. Common Stock PURCHASE AGREEMENTPurchase Agreement • September 14th, 2022 • POINT Biopharma Global Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 14th, 2022 Company Industry JurisdictionPIPER SANDLER & CO. GUGGENHEIM SECURITIES, LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Sandler & Co. U.S. Bancorp Center 800 Nicollet Mall Minneapolis, Minnesota 55402 c/o Guggenheim Securities, LLC 330 Madison Avenue New York, New York 10017 Ladies and Gentlemen: